BR
Healthcare & Life Sciences
Braveheart
United Statesbraveheart.bio
Braveheart is a Healthcare & Life Sciences startup based in the United States.
About Braveheart
Braveheart is a company headquartered in the United States. Brouky classifies it under Healthcare & Life Sciences.
Braveheart is developing BHB-1893, a selective small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy, a rare heart muscle disease, through global late-stage clinical development.
Explore Braveheart's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.